Data on a new sensitivity-improved miniaturized label-free electrochemical biosensor.

Area of Science:

• Biomedical Engineering
• Electrochemistry
• Biomarker Detection

Background:

• Cardiovascular diseases (CVD) pose a significant global health challenge.
• Accurate and early diagnosis of CVD is crucial for effective treatment.
• Existing diagnostic methods may lack the required sensitivity or speed.

Purpose of the Study:

• To introduce a new, highly sensitive electrochemical measurement architecture for CVD diagnosis.
• To improve the detection of key CVD biomarkers: S100 beta protein and C-reactive protein (CRP).
• To enhance reaction conditions for biomolecules using a novel biochip design.

Main Methods:

• Development of a new electrochemical measurement set-up.
• Integration of a novel biochip design to optimize molecular interactions.
• Conducting electrochemical measurement experiments to validate the architecture's performance.

Main Results:

• The new architecture demonstrated improved sensitivity for detecting CVD biomarkers.
• Optimized reaction conditions facilitated enhanced detection of S100 beta protein and CRP.
• Experimental results align with previous findings on miniaturized label-free electrochemical biosensors.

Conclusions:

• The developed electrochemical architecture offers a promising approach for sensitive CVD diagnosis.
• The improved biochip design and measurement set-up enhance biomarker detection capabilities.
• This work contributes to the advancement of electrochemical biosensors for clinical applications.